Home › Funds › Slocum, Gordon & Co LLP › JNJ

Slocum, Gordon & Co LLP position in JNJ

JOHNSON JOHNSON · Health Care

Slocum, Gordon & Co LLP reported holding 40,277 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$10.7M, representing 7.44% of its reported portfolio and ranking #2 among its reported holdings. Slocum, Gordon & Co LLP has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)40.28K sh
Reported value held$10.66M
Portfolio Weight7.44%
First reportedQ3 2023
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How Slocum, Gordon & Co LLP's JNJ position evolved

Slocum, Gordon & Co LLP first disclosed a stake in JNJ in Q3 2023 at 52,335 shares (US$8.2M). The position peaked in Q2 2026 at 42,489 shares, worth US$10.8M. Across 13 filings, Slocum, Gordon & Co LLP increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 40,277 shares valued at US$10.7M — a reduction of -2,212 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 52.34K $8.15M New
Q4 2023 52.23K $8.19M Hold
Q1 2024 51.90K $8.21M Reduce
Q2 2024 51.51K $7.53M Reduce
Q3 2024 49.61K $8.04M Reduce
Q4 2024 47.35K $6.85M Reduce
Q1 2025 46.83K $7.77M Reduce
Q2 2025 43.86K $6.70M Reduce
Q3 2025 43.78K $8.12M Hold
Q4 2025 43.43K $8.99M Reduce
Q1 2026 43.13K $10.54M Reduce
Q2 2026 42.49K $10.79M Reduce
Q3 2026 40.28K $10.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Slocum, Gordon & Co LLP held JNJ?

Slocum, Gordon & Co LLP has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Slocum, Gordon & Co LLP's current position in JNJ?

As of Q3 2026, Slocum, Gordon & Co LLP holds 40.28K shares of JNJ (JOHNSON JOHNSON), valued at $10.66M, representing 7.44% of its reported portfolio and ranking #2.

Has Slocum, Gordon & Co LLP been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Slocum, Gordon & Co LLP reduced its position in JNJ. The position peaked in Q2 2026 at 42.49K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.